{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:58:24Z","timestamp":1777877904822,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"abstract":"<jats:p>\n                    Traumatic spinal cord injury (TSCI) involves dynamic pathophysiological processes, including primary mechanical damage and secondary inflammatory cascades. Early biomarkers to assess injury severity and predict recovery remain limited. To evaluate serum cholinesterase (ChE) as a biomarker for neurological outcomes in TSCI patients. In this retrospective cohort study, 80 cervical TSCI patients (stratified by ASIA impairment scale [AIS]: groups A\u2013D) and 60 healthy controls were analyzed. Serum ChE levels were measured on days 1, 7, and 14 post-injury. Clinical outcomes and correlations between ChE levels and neurological recovery were assessed using analysis of variance, \u03c7\u00b2 tests, and Spearman\u2019s analysis. ChE levels did not differ across groups at day 1. By days 7 and 14, ChE levels significantly decreased in all TSCI groups compared to controls (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Severe injury groups (AIS A\/B) exhibited lower ChE levels than milder groups (AIS C\/D) at both timepoints (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Lower baseline ChE correlated with poorer neurological recovery and stronger associations with inflammatory\/oxidative stress markers. Serum ChE levels inversely correlate with TSCI severity and predict long-term neurological outcomes, highlighting its potential as a prognostic biomarker.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043922","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T21:02:19Z","timestamp":1756846939000},"page":"e43922","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serum cholinesterase (ChE) as an emerging biomarker in traumatic spinal cord injury: A retrospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"given":"Yongchang","family":"Li","sequence":"first","affiliation":[{"name":"Trauma Intensive Care Unit, Changzhou Second People\u2019s Hospital, Changzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyun","family":"Shen","sequence":"additional","affiliation":[{"name":"Trauma Intensive Care Unit, Changzhou Second People\u2019s Hospital, Changzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260430","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1017\/S0317167100014530","article-title":"Global incidence and prevalence of traumatic spinal cord injury.","volume":"40","author":"Furlan","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"R2-20260430","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/neu.2006.23.318","article-title":"Pharmacological approaches to repair the injured spinal cord.","volume":"23","author":"Baptiste","year":"2006","journal-title":"J Neurotrauma"},{"key":"R3-20260430","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC.2008.25.11.E2","article-title":"Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon.","volume":"25","author":"Rowland","year":"2008","journal-title":"Neurosurg Focus"},{"key":"R4-20260430","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.spinee.2003.07.007","article-title":"Pathophysiology and pharmacologic treatment of acute spinal cord injury.","volume":"4","author":"Kwon","year":"2004","journal-title":"Spine J"},{"key":"R5-20260430","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1089\/neu.2018.6208","article-title":"Optical assessment of spinal cord tissue oxygenation using a miniaturized near infrared spectroscopy sensor.","volume":"36","author":"Shadgan","year":"2019","journal-title":"J Neurotrauma"},{"key":"R6-20260430","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/089771504323004575","article-title":"The pathology of human spinal cord injury: defining the problems.","volume":"21","author":"Norenberg","year":"2004","journal-title":"J Neurotrauma"},{"key":"R7-20260430","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.3390\/ijms16047900","article-title":"Posttraumatic inflammation as a key to neuroregeneration after traumatic spinal cord injury.","volume":"16","author":"Moghaddam","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R8-20260430","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41393-019-0319-8","article-title":"Neurochemical biomarkers in spinal cord injury.","volume":"57","author":"Kwon","year":"2019","journal-title":"Spinal Cord"},{"key":"R9-20260430","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/s12885-019-6004-7","article-title":"Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer.","volume":"19","author":"Xiao","year":"2019","journal-title":"BMC Cancer"},{"key":"R10-20260430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12885-016-2276-3","article-title":"The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis.","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"R11-20260430","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-20-3209","article-title":"HDAC2 facilitates pancreatic cancer metastasis.","volume":"82","author":"Krau\u00df","year":"2022","journal-title":"Cancer Res"},{"key":"R12-20260430","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ijc.29084","article-title":"Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis.","volume":"136","author":"Kunutsor","year":"2015","journal-title":"Int J Cancer"},{"key":"R13-20260430","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","article-title":"Butyrylcholinesterase as a prognostic marker: a review of the literature.","volume":"4","author":"Santarpia","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R14-20260430","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1016\/j.clgc.2018.07.002","article-title":"Prognostic value of serum cholinesterase in non-muscle-invasive bladder cancer.","volume":"16","author":"Kimura","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"R15-20260430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPA.0b013e31815b6b2b","article-title":"Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.","volume":"36","author":"Mitsunaga","year":"2008","journal-title":"Pancreas"},{"key":"R16-20260430","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0973-1482.165869","article-title":"Serum butyrylcholinesterase and zinc in breast cancer.","volume":"13","author":"Kumar","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R17-20260430","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.21873\/anticanres.13217","article-title":"Combination of serum albumin and cholinesterase levels as prognostic indicator in patients with colorectal cancer.","volume":"39","author":"Yamamoto","year":"2019","journal-title":"Anticancer Res"},{"key":"R18-20260430","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/carcin\/bgi250","article-title":"Cholinesterase activity of human lung tumours varies according to their histological classification.","volume":"27","author":"Martinez-Moreno","year":"2006","journal-title":"Carcinogenesis"},{"key":"R19-20260430","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury.","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R20-20260430","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/10790268.2017.1329076","article-title":"Assessment and management of acute spinal cord injury: from point of injury to rehabilitation.","volume":"40","author":"Hachem","year":"2017","journal-title":"J Spinal Cord Med"},{"issue":"3_suppl","key":"R21-20260430","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1177\/21925682231197404","article-title":"Timing of decompressive surgery in patients with acute spinal cord injury: systematic review update.","volume":"14","author":"Fehlings","year":"2024","journal-title":"Global Spine J"},{"key":"R22-20260430","first-page":"CD001046","article-title":"Steroids for acute spinal cord injury.","volume":"1","author":"Bracken","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20260430","doi-asserted-by":"crossref","first-page":"e18118","DOI":"10.1111\/jcmm.18118","article-title":"Effect of fentanyl and remifentanil on neuron damage and oxidative stress during induction neurotoxicity.","volume":"28","author":"Taghizadehghalehjoughi","year":"2024","journal-title":"J Cell Mol Med"},{"key":"R24-20260430","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/ph13100318","article-title":"Attenuation of spatial memory in 5xFAD mice by halting cholinesterases, oxidative stress and neuroinflammation using a cyclopentanone derivative.","volume":"13","author":"Ullah","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"R25-20260430","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/0118715273258337230925040049","article-title":"Montelukast ameliorates scopolamine-induced Alzheimer\u2019s disease: role on cholinergic neurotransmission, antioxidant defence system, neuroinflammation and expression of BDNF.","volume":"23","author":"Yerraguravagari","year":"2024","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:05:38Z","timestamp":1777590338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":25,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043922","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"2025-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}